We have addressed each of the reviewers comments point by point below, and marked all changes to the revised manuscript in red.
|
|
- Sherilyn Morton
- 6 years ago
- Views:
Transcription
1 Author s response to reviews Title: A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review Authors: Takashi Hosaka (dagasi1985@yahoo.co.jp) Kazuhiro Ishii (kazishii@md.tsukuba.ac.jp) Takeshi Miura (tmiur@bri.niigata-u.ac.jp) Naomi Mezaki (nm8@bri.niigata-u.ac.jp) Kensaku Kasuga (ken39@bri.niigata-u.ac.jp) Takeshi Ikeuchi (ikeuchi@bri.niigata-u.ac.jp) Akira Tamaoka (atamaoka@md.tsukuba.ac.jp) Version: 1 Date: 18 Jul 2017 Author s response to reviews: 14 July 2017 Dear Editors, Re: NURL-D We kindly request that you consider our revised manuscript, entitled A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review for publication in BMC Neurology. We greatly appreciate the reviewers attention to our paper, and believe that their comments and suggestions were very constructive and strengthened the quality of our manuscript considerably. We have addressed each of the reviewers comments point by point below, and marked all changes to the revised manuscript in red.
2 Point-by-point response to the reviewers comments Daniela Galimberti (Reviewer 1): According to NCBI, the mutation should be named "p.pro373argx38" (NCBI Reference Sequence: NC_ ). Please check Thank you for your comment. We corrected p.pro373argfsx37 to p.pro373argx38 accordingly (Abstract, line 17, page 2; Case presentation, line 9, page 8; and Figures legends, line 9, page 17). The family history should be included, i.e. is the brother alive? Is there any information on her parents? The patient s brother and parents had already passed away at the time of writing this case. Therefore, we could not obtain their detailed clinical information. We added this explanation in the text (Case presentation, lines 16 17, page 5). Introduction: additional examples of phenotypic heterogeneity should be included (JAD 2011;24;253-9 and 2011;23:7-12) As you suggested, we added There are also reports of clinical heterogeneity within a family. in the Background section (lines 16 17, page 4). We also added the following references to the text and Table 1: Pietroboni AM, Fumagalli GG, Ghezzi L, Fenoglio C, Cortini F, Serpente M, et al. Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred. J. Alzheimers Dis. 2011;24: Rossi G, Piccoli E, Benussi L, Caso F, Redaelli V, Magnani G, et al. A novel progranulin mutation causing frontotemporal lobar degeneration with heterogeneous phenotypic expression. J. Alzheimers Dis. 2011;23:7 12. Discussion: beside clinical heterogeneity associated with the same mutation, it should be acknowledged that sometimes the same mutations results in the same phenotype in monozygotic twin pairs (Neurology 2012; 78(16):1245-9).
3 As you suggested, we added Similar symptoms, neuropsychological profile, and neuroimaging findings have been reported in a monozygotic twin pair with a GRN mutation. in the Discussion section (lines 9 10, page 9). We also added the following reference to the text: McDade E, Boeve BF, Burrus TM, Boot BP, Kantarci K, Fields J, et al. Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulin. Neurology 2012;78: David Weidman (Reviewer 2): 1) Regarding the Western Aphasia Battery from the description in the paper, it is not clear that an auditory verbal comprehension subtest was administered (doesn't seem like it was done). While different subtests can be chosen for the WAB, if "visual input" tasks were done, by which I assume that means reading comprehension, I think that merits that a complementary auditory comprehension test(s) be done. There is a later reference to retained ability to understand words, but objective means of establishing that should include auditory comprehension Thank you for your suggestion. We revised the text as follows: Language function was assessed using the Western Aphasia Battery (WAB) Japanese edition once and SLTA (standard language test of aphasia) two times within two months. The scores of WAB subtests were as follows: spontaneous speech, 13 points; auditory verbal comprehension, 5.5 points; repetition, 0 points; naming, 0 points; reading, 4.3 points; writing, 2.2 points; praxis, 6.8 points; and construction, drawing, block design & calculation, 6.6 points. Raven s score was 25/37 (average ± standard deviation: 26.9 ± 5.4). Aphasia quotient was The results of SLTA were similar to those of WAB. Naming, writing, and repetition were impaired. However, auditory verbal comprehension and reading concerning words and short sentences were relatively preserved. Spatial perception and visual perception were also normal. Verbal comprehension via visual perception was approximately normal. Therefore, it is likely that auditory verbal comprehension was complemented by visual perception. (Case presentation, lines 7 17, page 6). 2) Regarding the patient's elder brother being diagnosed as having CBS, it's not clear if that's purely clinically. Does this imply that there was no genetic analysis of the brother? Is he deceased, so no blood available, and if he was deceased at the time of the genetic analysis of the patient, had a brain autopsy been carried out?
4 If these details of the elder brother can't be ascertained, would state this limitation in the discussion paragraph The patient s brother had already passed away and a brain autopsy was not carried out. Therefore, we could not perform a genetic analysis. Moreover, he was diagnosed as CBS in another hospital and we could not obtain his detailed clinical information. We added some of this information in the Discussion paragraph (Discussion and conclusions, lines 11 13, page 9). 3) Regarding the first discussion paragraph, the phrase: "whereas behavioral disinhibition and memory impairments were not observed in the early stages of disease", I'd suggest adding "and executive function", to the retained function early on, if that was the case in this patient, since bvftd may present as disinhibition (orbital frontal) or executive dysfunction, reduced planning (dorsolateral frontal). Perhaps can read: "whereas behavioral disinhibition, executive dysfunction and memory impairment were not impaired " Thank you for your comment. We corrected whereas behavioral disinhibition and memory impairments were not observed in the early stages of disease to whereas behavioral disinhibition, executive function, and memory impairments were not impaired in the early stages of disease (Discussion and conclusions, lines 4 5, page 9). 4) Contrasting haploinsufficiency in autosomal dominant genetic conditions, compared to recessive, perhaps a brief comment, or perhaps contrasting with a toxic gain of function or toxicity of excessive proteins in many autosomal dominant conditions (eg, familial AD, early onset, PSN-1) Haploinsufficiency is a cause of autosomal genetic conditions when the protein expressed by a single allele is not sufficient to maintain its normal function. It differs from recessive disease. As you commented, in many autosomal dominant conditions, toxic gain of function or toxicity of excessive proteins are the cause of disease. However, haploinsufficiency causes disease by loss of function. Actually, in cases of mutated GRN, loss-of-function mutations have been reported as the cause of FTLD. As described in the text, in a heterozygous GRN mutation carrier, there is an approximate 50% decrease in mrna and 33% decrease in progranulin protein levels. In our case, a mutant allele product was not detected, suggesting degradation of the mutant allele by the nonsense-mediated RNA decay system; haploinsufficiency due to reduced expression of progranulin was considered to be a possible pathogenic mechanism (Case presentation, lines 12 14, page 8; Discussion and conclusions, lines 8 11, page 10).
5 We added the following references: Cook DL, Gerber AN, Tapscott SJ. Modeling stochastic gene expression: implications for haploinsufficiency. Proc. Natl. Acad. Sci. U. S. A. 1998;95: Davis JA, Naruse S, Chen H, Eckman C, Younkin S, Price DL. An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos. Neuron 1998;20: Qian S, Jiang P, Guan XM, Singh G, Trumbauer ME, Yu H. Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates Abeta1-42/43 expression. Neuron. 1998;20: We correct understood to understand (Case presentation, line 10, page 7) and revised the reference numbers because some references were added. We greatly appreciate your consideration concerning the publication of our manuscript. Sincerely, Dr. Kazuhiro Ishii Department of the Neurology, Division of Clinical Medicine Faculty of Medicine, University of Tsukuba Ten'noudai, Tsukuba, Ibaraki, , Japan Tel: , Fax: kazishii@md.tsukuba.ac.jp
Takashi Hosaka 1, Kazuhiro Ishii 1*, Takeshi Miura 2,3, Naomi Mezaki 2,3, Kensaku Kasuga 2, Takeshi Ikeuchi 2 and Akira Tamaoka 1
Hosaka et al. BMC Neurology (2017) 17:182 DOI 10.1186/s12883-017-0959-2 CASE REPORT Open Access A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype
More informationThe frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer
The frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer MRC Clinician Scientist Honorary Consultant Neurologist Dementia Research Centre, UCL Institute of Neurology
More informationPerspectives on Frontotemporal Dementia and Primary Progressive Aphasia
Perspectives on Frontotemporal Dementia and Primary Progressive Aphasia Bradley F. Boeve, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota Alzheimer s Disease
More informationDo not copy or distribute without permission. S. Weintraub, CNADC, NUFSM, 2009
Sandra Weintraub, Ph.D. Clinical Core Director, Cognitive Neurology and Alzheimer s Disease Center Northwestern University Feinberg School of Medicine Chicago, Illinois Dementia: a condition caused by
More informationObjectives. RAIN Difficult Diagnosis 2014: A 75 year old woman with falls. Case History: First visit. Case History: First Visit
Objectives RAIN Difficult Diagnosis 2014: A 75 year old woman with falls Alexandra Nelson MD, PhD UCSF Memory and Aging Center/Gladstone Institute of Neurological Disease Recognize important clinical features
More information! slow, progressive, permanent loss of neurologic function.
UBC ! slow, progressive, permanent loss of neurologic function.! cause unknown.! sporadic, familial or inherited.! degeneration of specific brain region! clinical syndrome.! pathology: abnormal accumulation
More informationPsychological Tests that Examine Brain Functioning
Psychological Tests that Examine Brain Functioning Psychology 372 Physiological Psychology Steven E. Meier, Ph.D. Listen to the audio lecture while viewing these slides or view the video presentation available
More informationRE: Title: Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis
September 10, 2018 Professor Xue-Jiao Wang, MD Science Editor Editorial Office 'World Journal of Gastroenterology' RE: 40814 Title: Practical fecal calprotectin cut-off value for Japanese patients with
More informationClinical Genetics & Dementia
Clinical Genetics & Dementia Dr Nayana Lahiri Consultant in Clinical Genetics & Honorary Senior Lecturer Nayana.lahiri@nhs.net Aims of the Session To appreciate the potential utility of family history
More informationForm D1: Clinician Diagnosis
Initial Visit Packet Form D: Clinician Diagnosis NACC Uniform Data Set (UDS) ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to be completed by the clinician.
More informationFTD basics! Etienne de Villers-Sidani, MD!
FTD basics! Etienne de Villers-Sidani, MD! Frontotemporal lobar degeneration (FTLD) comprises 3 clinical syndromes! Frontotemporal dementia (behavioral variant FTD)! Semantic dementia (temporal variant
More informationLANGUAGE AND PATHOLOGY IN FRONTOTEMPORAL DEGENERATION
LANGUAGE AND PATHOLOGY IN FRONTOTEMPORAL DEGENERATION Murray Grossman University of Pennsylvania Support from NIH (AG17586, AG15116, NS44266, NS35867, AG32953, AG38490), IARPA, ALS Association, and the
More informationFTD/PPA Caregiver Education Conference March 11, 2011
FTD/PPA Caregiver Education Conference March 11, 2011 Question and Answer Session Answered by Joseph Cooper, MD, Darby Morhardt, MSW, LCSW, Mary O Hara, AM, LCSW, Jaimie Robinson, MSW, LCSW, Emily Rogalski,
More informationI do not have any disclosures
Alzheimer s Disease: Update on Research, Treatment & Care Clinicopathological Classifications of FTD and Related Disorders Keith A. Josephs, MST, MD, MS Associate Professor & Consultant of Neurology Mayo
More informationTitle:Cognitive profile in patients with a first-ever lacunar infarct with and without silent lacunes: a comparative study.
Author's response to reviews Title:Cognitive profile in patients with a first-ever lacunar infarct with and without silent lacunes: a comparative study. Authors: Lorena Blanco-Rojas (l.blanco.rojas@copc.cat)
More informationWhite matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration
White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration Annual Scientific Meeting Canadian Geriatric Society Philippe Desmarais,
More informationProposal form for the evaluation of a genetic test for NHS Service Gene Dossier
Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Leber congenital amaurosis OMIM number for disease 204000 Disease alternative
More informationObjectives. Objectives continued: 3/24/2012. Copyright Do not distribute or replicate without permission 1
Frontotemporal Degeneration and Primary Progressive Aphasia Caregiver and Professional Education Conference Diana R. Kerwin, MD Assistant Professor of Medicine-Geriatrics Cognitive Neurology and Alzheimer
More informationPsychology of Language
PSYCH 150 / LIN 155 UCI COGNITIVE SCIENCES syn lab Psychology of Language Prof. Jon Sprouse 01.24.13: Williams Syndrome and Specific Language Impairment 1 Is there a language faculty? Do the processes
More informationTitle: Use of food labels by adolescents to make healthier choices on snacks: a cross sectional study from Sri Lanka
Author s response to reviews Title: Use of food labels by adolescents to make healthier choices on snacks: a cross sectional study from Sri Lanka Authors: Ishanka Talagala (drmaheshkeerthi@gmail.com;drishanka@gmail.com)
More informationEARLY ONSET FRONTOTERMPORAL DEMENTIA AND ALZHEIMERS DISEASE: DIAGNOSIS, TREATMENT AND CARE
EARLY ONSET FRONTOTERMPORAL DEMENTIA AND ALZHEIMERS DISEASE: DIAGNOSIS, TREATMENT AND CARE John Rudge, BA Hons This thesis is presented as partial requirement for the degree of Doctor of Psychology at
More informationAuthor s response to reviews
Author s response to reviews Title: The involvement of young people in school- and community-based noncommunicable disease prevention interventions: a scoping review of designs and outcomes Authors: Didier
More informationUNIVERSITY OF CALIFORNIA, LOS ANGELES
UNIVERSITY OF CALIFORNIA, LOS ANGELES BERKELEY DAVIS IRVINE LOS ANGELES MERCED RIVERSIDE SAN DIEGO SAN FRANCISCO UCLA SANTA BARBARA SANTA CRUZ DEPARTMENT OF EPIDEMIOLOGY SCHOOL OF PUBLIC HEALTH CAMPUS
More informationPedigree Construction Notes
Name Date Pedigree Construction Notes GO TO à Mendelian Inheritance (http://www.uic.edu/classes/bms/bms655/lesson3.html) When human geneticists first began to publish family studies, they used a variety
More informationTitle: MYBBP1A suppresses breast cancer tumorigenesis by enhancing the p53 dependent anoikis
Author's response to reviews Title: MYBBP1A suppresses breast cancer tumorigenesis by enhancing the p53 dependent anoikis Authors: Kensuke Akaogi (kensuke.akaogi@gmail.com) Wakana Ono (wakana315@gmail.com)
More informationFRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS
FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS Norman L. Foster, M.D. Director, Center for Alzheimer s Care, Imaging and Research Chief, Division of Cognitive Neurology, Department of Neurology
More informationMyelin suppresses axon regeneration by PIR-B/SHPmediated inhibition of Trk activity
Manuscript EMBO-2010-76298 Myelin suppresses axon regeneration by PIR-B/SHPmediated inhibition of Trk activity Yuki Fujita, Shota Endo, Toshiyuki Takai and Toshihide Yamashita Corresponding author: Toshihide
More information2016 Programs & Information
Mayo Alzheimer s Disease Research Clinic Education Center 2016 Programs & Information BROCHURE TITLE FLUSH RIGHT for Persons & Families impacted by Mild Cognitive Impairment Alzheimer s Disease Dementia
More informationNCRAD. Single Gene Implicated in FTD/ALS UCSF Memory and Aging Center, San Francisco, California
The National Cell Repository for Alzheimer s Disease (NCRAD) is a data and specimen collection source for families with Alzheimer disease (AD) or serious memory loss. Families having two or more living
More informationMCB140: Second Midterm Spring 2010
MCB140: Second Midterm Spring 2010 Before you start, print your name and student identification number (S.I.D) at the top of each page. There are 11 pages including this page. You will have 150 minutes
More informationTitle:Cerebrovascular function and cognition in childhood: a systematic review of transcranial doppler studies
Author's response to reviews Title:Cerebrovascular function and cognition in childhood: a systematic review of transcranial doppler studies Authors: Mireille J Bakker (mireille.j.bakker@gmail.com) Jessica
More informationTitle:Atypical language organization in temporal lobe epilepsy revealed by a passive semantic paradigm
Author's response to reviews Title:Atypical language organization in temporal lobe epilepsy revealed by a passive semantic paradigm Authors: Julia Miro (juliamirollado@gmail.com) Pablo Ripollès (pablo.ripolles.vidal@gmail.com)
More informationClinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA
Clinicopathologic and genetic aspects of hippocampal sclerosis Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA The hippocampus in health & disease A major structure of the medial temporal
More informationTitle: Quality of life in childhood epilepsy with lateralized focus
Author's response to reviews Title: Quality of life in childhood epilepsy with lateralized focus Authors: Krystyna A. Mathiak (krystyna.mathiak@psych.uw.edu.pl) Malgorzata Luba (malgosia.luba@gmail.com)
More informationAphasia And Associated Disorders: Taxonomy, Localization And Recovery By Andrew Kertesz
Aphasia And Associated Disorders: Taxonomy, Localization And Recovery By Andrew Kertesz If you are looking for a book by Andrew Kertesz Aphasia and Associated Disorders: Taxonomy, Localization and Recovery
More informationSandra Weintraub, PhD Clinical Core Leader and Professor
Sandra Weintraub, PhD Clinical Core Leader and Professor Northwestern Cognitive Neurology and Alzheimer s Disease Center (CNADC) Chicago, Illinois www.brain.northwestern.edu Why is it so difficult to diagnose
More informationWhat is. frontotemporal. address? dementia?
What is frontotemporal address? dementia? Contents 03 What is frontotemporal dementia? 04 Symptoms 05 Diagnosis 06 Treatments Information in this booklet is for anyone who wants to know more about frontotemporal
More informationEnglish Editing Samples
English Editing Samples Contents Advanced Edit... 2 Premium Edit... 3 Customized cover letter... 4 Feedback on original writing... 6 Editing certificate... 9 Journal response letter editing... 10 Advanced
More informationTitle:Video-confidence: a qualitative exploration of videoconferencing for psychiatric emergencies
Author's response to reviews Title:Video-confidence: a qualitative exploration of videoconferencing for psychiatric emergencies Authors: Marianne V Trondsen (marianne.trondsen@telemed.no) Stein Roald Bolle
More informationBIOL2005 WORKSHEET 2008
BIOL2005 WORKSHEET 2008 Answer all 6 questions in the space provided using additional sheets where necessary. Hand your completed answers in to the Biology office by 3 p.m. Friday 8th February. 1. Your
More informationTitle: Small cell carcinoma arising in Barrett's esophagus: a case report and review of the literature
Author's response to reviews Title: Small cell carcinoma arising in Barrett's esophagus: a case report and review of the literature Authors: Haridimos Markogiannakis (markogiannakis@easy.com) Dimitrios
More informationProposal form for the evaluation of a genetic test for NHS Service Gene Dossier
Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Choroideremia OMIM number for disease 303100 Disease alternative names please
More informationTitle:Continuity of GP care is associated with lower use of complementary and alternative medical providers A population-based cross-sectional survey
Author's response to reviews Title:Continuity of GP care is associated with lower use of complementary and alternative medical providers A population-based cross-sectional survey Authors: Anne Helen Hansen
More informationDementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology
Dementia Stephen S. Flitman, MD Medical Director 21st Century Neurology www.neurozone.org Dementia is a syndrome Progressive memory loss, plus Progressive loss of one or more cognitive functions: Language
More informationDEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD
DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD OBJECTIVES Terminology/Dementia Basics Most Common Types Defining features Neuro-anatomical/pathological underpinnings Neuro-cognitive
More informationFor carers and relatives of people with frontotemporal dementia and semantic dementia. Newsletter
For carers and relatives of people with frontotemporal dementia and semantic dementia Newsletter AUGUST 2008 1 Welcome Welcome to the August edition of our CFU Support Group Newsletter. Thanks to all of
More informationTitle: A survey of attitudes toward clinical research among physicians at Kyoto University Hospital
Author's response to reviews Title: A survey of attitudes toward clinical research among physicians at Kyoto University Hospital Authors: Eriko Sumi (sumieri@kuhp.kyoto-u.ac.jp) Toshinori Murayama (murayama@kuhp.kyoto-u.ac.jp)
More informationContents. Introduction. Introduction 03
Genes and dementia Introduction This information is for anyone who wants to know more about the link between genes and dementia. This includes people living with dementia, their carers, friends and families.
More informationProposal form for the evaluation of a genetic test for NHS Service Gene Dossier
Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Amyotrophic Lateral Sclerosis 10 (ALS10) and Amyotrophic Lateral Sclerosis 6 (ALS6)
More informationBody: Re Should the threshold for definition of impaired fasting glucose be lowered?
From: dme_editorial@wiley.com To: inouek@m.u-tokyo.ac.jp CC: dme_editorial@wiley.com Subject: Diabetic Medicine DME-2009-00292 Body: Re Should the threshold for definition of impaired fasting glucose be
More informationFrontotemporal dementia:
Frontotemporal dementia: Where we ve been What s on the horizon Howard Rosen, M.D. UCSF Department of Neurology Memory and Aging Center www.memory.ucsf.edu None Disclosures Overview FTD, What is it? Origins
More informationRESPONSE TO DECISION LETTER
RESPONSE TO DECISION LETTER Dear Editor-in-chief, We are grateful to the editors and reviewers for their time and constructive comments on our manuscript. We have implemented their comments and suggestions
More informationRole of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases
Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases Keith A. Josephs, MD, MST, MSc Professor of Neurology 13th Annual Mild Cognitive Impairment (MCI) Symposium: Alzheimer and Non-Alzheimer
More informationCover Letter. Reviewer 1:
Cover Letter Michael Yang, M.D., Ph.D. Managing Editor of Cancer Research Frontiers 1188 Willis Ave, #109, Albertson, NY 11507, USA Phone: +1-917-426-1571 http://cancer-research-frontiers.org/ Dear Dr.
More informationSingle Gene (Monogenic) Disorders. Mendelian Inheritance: Definitions. Mendelian Inheritance: Definitions
Single Gene (Monogenic) Disorders Mendelian Inheritance: Definitions A genetic locus is a specific position or location on a chromosome. Frequently, locus is used to refer to a specific gene. Alleles are
More informationDementia Past, Present and Future
Dementia Past, Present and Future Morris Freedman MD, FRCPC Division of Neurology Baycrest and University of Toronto Rotman Research Institute, Baycrest CNSF 2015 Objectives By the end of this presentation,
More informationProf Tim Anderson. Neurologist University of Otago Christchurch
Prof Tim Anderson Neurologist University of Otago Christchurch Tim Anderson Christchurch Insidious cognitive loss From subjective memory complaints (SMC) to dementia Case 1. AR. 64 yrs Male GP referral
More informationWhat favorite organism of geneticists is described in the right-hand column?
What favorite organism of geneticists is described in the right-hand column? Model Organism fruit fly?? Generation time 12 days ~ 5000 days Size 2 mm 1500-1800mm Brood size hundreds a couple dozen would
More informationFTD Genetics: for patients and families. Kirk Wilhelmsen, M.D., Ph.D UNC
FTD Genetics: for patients and families Kirk Wilhelmsen, M.D., Ph.D UNC UNC The Human Genome 22 Pairs of Chromosomes 2 Sex Chromosomes 3,300,000,000 basepairs of DN 7-14 picograms of DN per cell ~20,000
More informationPresenter Disclosure Information. I have no financial relationships to disclose:
Sandra Weintraub, Ph.D. Cognitive Neurology and Alzheimer s Disease Center Northwestern University, Feinberg School of Medicine Chicago, Illinois http://www.brain.northwestern.edu/dementia/ppa/index.html
More informationForm A3: Subject Family History
Initial Visit Packet NACC Uniform Data Set (UDS) Form A: Subject Family History ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to be completed by a clinician
More informationvariant led to a premature stop codon p.k316* which resulted in nonsense-mediated mrna decay. Although the exact function of the C19L1 is still
157 Neurological disorders primarily affect and impair the functioning of the brain and/or neurological system. Structural, electrical or metabolic abnormalities in the brain or neurological system can
More informationTitle: Healthy snacks at the checkout counter: A lab and field study on the impact of shelf arrangement and assortment structure on consumer choices
Author's response to reviews Title: Healthy snacks at the checkout counter: A lab and field study on the impact of shelf arrangement and assortment structure on consumer choices Authors: Ellen van Kleef
More informationTitle: Association of interleukin-33 and thymic stromal lymphopoietin levels with the development of idiopathic pulmonary fibrosis
Author s response to reviews Title: Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis Authors: Jong-Uk Lee (lajoal@nate.com) Hun Soo Chang
More informationInteraction of Genes and the Environment
Some Traits Are Controlled by Two or More Genes! Phenotypes can be discontinuous or continuous Interaction of Genes and the Environment Chapter 5! Discontinuous variation Phenotypes that fall into two
More informationDementia Update. Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota
Dementia Update Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota Nothing to disclose Dementia Progressive deterioration in mental function
More informationTitle: Do general practitioners and psychiatrists agree about defining cure from depression? The DESCRIBE survey
Author's response to reviews Title: Do general practitioners and psychiatrists agree about defining cure from depression? The DESCRIBE survey Authors: koen demyttenaere (koen.demyttenaere@med.kuleuven.be)
More informationName Class Date. KEY CONCEPT The chromosomes on which genes are located can affect the expression of traits.
Section 1: Chromosomes and Phenotype KEY CONCEPT The chromosomes on which genes are located can affect the expression of traits. VOCABULARY carrier sex-linked gene X chromosome inactivation MAIN IDEA:
More informationWhat is frontotemporal dementia?
What is frontotemporal dementia? Introduction Information in this introductory booklet is for anyone who wants to know more about frontotemporal dementia (FTD). This includes people living with FTD, their
More informationTitle: Translational Models for Vascular Cognitive Impairment. A Review Including Larger Species
Author s response to reviews Title: Translational Models for Vascular Cognitive Impairment. A Review Including Larger Species Authors: Atticus Hainsworth (ahainsworth@sgul.ac.uk) Stuart Allan (stuart.allan@manchester.ac.uk)
More informationHuman Molecular Genetics Prof. S. Ganesh Department of Biological Sciences and Bioengineering Indian Institute of Technology, Kanpur
Human Molecular Genetics Prof. S. Ganesh Department of Biological Sciences and Bioengineering Indian Institute of Technology, Kanpur Module - 02 Lecture - 06 Let us test your understanding of Pedigree
More informationChanges in Chronic Global Aphasia at Impairment and Functional Communication Levels following SGD Practice and Use. Richard. D. Steele Lingraphica
Steele, R.D. Changes in Chronic Global Aphasia at Impairment and Functional Communication Levels following SGD Practice and Use. Paper presented at the 2008 Clinical AAC Research Conference, Charlottesville,
More informationProposal form for the evaluation of a genetic test for NHS Service Gene Dossier
Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Epileptic encephalopathy, early infantile 4. OMIM number for disease 612164 Disease
More informationAtlas of Genetics and Cytogenetics in Oncology and Haematology
Atlas of Genetics and Cytogenetics in Oncology and Haematology Genetic Counseling I- Introduction II- Motives for genetic counseling requests II-1. Couple before reproduction II-2. Couple at risk III-
More informationAdapting Patient Provider. with Communication Disorders
Adapting Patient Provider Communication with Individuals with Communication Disorders On line content slides In preparing for your upcoming seminar, please become familiar with the following information
More informationFrontotemporal Dementia: Towards better diagnosis. Frontotemporal Dementia. John Hodges, NeuRA & University of New South Wales, Sydney.
I.1 I.2 II.1 II.2 II.3 II.4 II.5 II.6 III.1 III.2 III.3 III.4 III.5 III.6 III.7 III.8 III.9 III.10 III.11 III.12 IV.1 IV.2 IV.3 IV.4 IV.5 Frontotemporal Dementia: Towards better diagnosis Frontotemporal
More informationPathways Toward Translational Research Programs for ASD. Helen Tager-Flusberg, Ph.D. Boston University NJ Governor s Council Conference April 9, 2014
Pathways Toward Translational Research Programs for ASD Helen Tager-Flusberg, Ph.D. Boston University NJ Governor s Council Conference April 9, 2014 ASD Research History For several decades research on
More informationAuthor s response to reviews
Author s response to reviews Title: Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer Authors: Lei Zhao (zhaoleilei0507@126.com)
More informationTitle: Intention-to-treat and transparency of related practices in randomized, controlled trials of anti-infectives
Author s response to reviews Title: Intention-to-treat and transparency of related practices in randomized, controlled trials of anti-infectives Authors: Robert Beckett (rdbeckett@manchester.edu) Kathryn
More informationAssessment Schedule 2015 Biology: Demonstrate understanding of genetic variation and change (91157)
NCEA Level 2 Biology (91157) 2015 page 1 of 6 Assessment Schedule 2015 Biology: Demonstrate understanding of genetic variation and change (91157) Assessment Criteria Achievement Achievement with Merit
More informationLaboratory. Mendelian Genetics
Laboratory 9 Mendelian Genetics Biology 171L FA17 Lab 9: Mendelian Genetics Student Learning Outcomes 1. Predict the phenotypic and genotypic ratios of a monohybrid cross. 2. Determine whether a gene is
More informationNon Alzheimer Dementias
Non Alzheimer Dementias Randolph B Schiffer Department of Neuropsychiatry and Behavioral Science Texas Tech University Health Sciences Center 9/11/2007 Statement of Financial Disclosure Randolph B Schiffer,,
More informationMEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG)
Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG) Ordering Information Acceptable specimen types: Fresh blood sample (3-6 ml EDTA; no time limitations associated with receipt)
More informationAuthor's response to reviews
Author's response to reviews Title: EPHB2 germline variants in patients with colorectal cancer or hyperplastic polyposis Authors: Antti Kokko (antti.kokko@helsinki.fi) Paivi Laiho (paivi.laiho@helsinki.fi)
More informationTitle: Prevalence and incidence of multiple sclerosis in central Poland,
Author s response to reviews Title: Prevalence and incidence of multiple sclerosis in central Poland, 2010-2014 Authors: Waldemar Brola (wbrola@wp.pl) Piotr Sobolewski (piotrsobolewski@poczta.onet.pl)
More informationAuthor s response to reviews
Author s response to reviews Title: Prevalence of chronic hepatitis B virus infection and infrastructure for its diagnosis in Madagascar: implication for the WHO's elimination strategy Authors: Soa Fy
More information3/7/2017. Alzheimer s and Dementia Research: An Advanced Discussion. Alzheimer s and Dementia Research: An Advanced Discussion
Alzheimer s and Dementia Research: An Advanced Discussion Brad Boeve, MD Department of Neurology Mayo Clinic Alzheimer s and Dementia Research: An Advanced Discussion Theoretical Constructs in Aging/Dementia
More informationBelow are the sections of the DNA sequences of a normal hemoglobin gene and the mutated gene that causes sickle cell disease.
Sickle Cell Analysis Directions: Read the information below to complete the two tables. A person with sickle-cell disease has the genotype: Hb s Hb s. People who have this condition have two abnormal genes,
More informationLab Activity Report: Mendelian Genetics - Genetic Disorders
Name Date Period Lab Activity Report: Mendelian Genetics - Genetic Disorders Background: Sometimes genetic disorders are caused by mutations to normal genes. When the mutation has been in the population
More informationEffects of Response Elaboration Training on Increased Length and Complexity of Utterances with Two Participants with Fluent Aphasia
Effects of Response Elaboration Training on Increased Length and Complexity of Utterances with Two Participants with Fluent Aphasia Response Elaboration Training (RET; Kearns, 1985) is a treatment approach
More informationAP Biology Summer Assignment Cory Doubek,
AP Biology Summer Assignment Cory Doubek, cdoubek@aacps.org AP Biology builds on the fundamentals that you learned in standard biology. In order to ensure that you are ready to go when we begin in September,
More informationRecent publications using the NACC Database. Lilah Besser
Recent publications using the NACC Database Lilah Besser Data requests and publications Using NACC data Number of requests by year Type 2009 2010 2011 2012 2013 2014 2015 Data files* 55 85 217 174 204
More informationTitle:Fulvic acid attenuates homocysteine-induced cyclooxygenase-2 expression in human monocytes
Author's response to reviews Title:Fulvic acid attenuates homocysteine-induced cyclooxygenase-2 expression Authors: Shao-Ju Chien (csjdc@adm.cgmh.org.tw) Te-Chuan Chen (ma4671@gmail.com) Hsing-Chun Kuo
More informationMethods. Preliminary Results
Parkinson s disease (PD) is one of the most common neurodegenerative diseases, afflicting approximately 1% of adults by age 65 (Shulman et al., 2011). Whereas PD typically presents with a variety of motoric
More informationA novel fragile X syndrome mutation reveals a conserved role for the carboxy-terminus in FMRP localization and function
A novel fragile X syndrome mutation reveals a conserved role for the carboxy-terminus in FMRP localization and function Zeynep Okray, Celine E.F. de Esch, Hilde Van Esch, Koen Devriendt, Annelies Claeys,
More informationPatient Identification: Patient Name (first, middle, last)
Patient Identification: Patient Name (first, middle, last) Patient s USIDNET Registry Number assigned after online enrollment Date of Birth / / (mm/dd/yyyy) or Year of Birth Gender: male [ ], female [
More informationCerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup
Woollacott et al. Alzheimer's Research & Therapy (2018) 10:79 https://doi.org/10.1186/s13195-018-0405-8 RESEARCH Open Access Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by
More informationManuscript ID BMJ R1 entitled "Education and coronary heart disease: a Mendelian randomization study"
BMJ - Decision on Manuscript ID BMJ.2017.03 7504.R1 Body: 11-May-2017 Dear Dr. Tillmann Manuscript ID BMJ.2017.037504.R1 entitled "Education and coronary heart disease: a Mendelian randomization study"
More informationGenetics of Behavior (Learning Objectives)
Genetics of Behavior (Learning Objectives) Recognize that behavior is multi-factorial with genetic components Understand how multi-factorial traits are studied. Explain the terms: incidence, prevalence,
More informationWhat is the inheritance pattern (e.g., autosomal, sex-linked, dominant, recessive, etc.)?
Module I: Introduction to the disease Give a brief introduction to the disease, considering the following: the symptoms that define the syndrome, the range of phenotypes exhibited by individuals with the
More information